Last quarter (Q4 2022), Addex Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Addex Therapeutics's net income was $―. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 830.01K	$ 1.42M	$ 2.92M	$ 3.61M	$ 2.76M	$ 6.04M
Cost of Revenue	-	$ -21.97M	-	-	-	-
Gross Profit	-	$ 1.42M	$ 2.92M	-	-	-
Operating Expense	$ 17.85M	$ 22.28M	$ 18.72M	$ 15.86M	$ 17.37M	$ 7.47M
Operating Income	$ -17.02M	$ -20.86M	$ -15.81M	$ -12.24M	$ -14.60M	$ -1.43M
Net Non Operating Interest Income Expense	$ -76.06K	$ 29.25K	$ 217.01K	$ -34.20K	$ -91.64K	$ -134.31K
Other Income Expense	$ -54.79K	$ -22.52K	$ -497.55K	$ -581.13K	$ -84.80K	$ -85.87K
Pretax Income	$ -17.15M	$ -20.80M	$ -15.35M	$ -12.86M	$ -14.78M	$ -1.64M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -17.15M	$ -19.53M	$ -15.09M	$ -12.86M	$ -14.78M	$ -1.64M
Basic EPS	$ -2.04	$ -0.46	$ -0.45	$ -2.88	$ -3.36	$ -0.42
Diluted EPS	$ -2.04	$ -0.46	$ -0.45	$ -2.88	$ -3.36	$ -0.42
Basic Average Shares	$ 12.56M	$ 45.18M	$ 33.54M	$ 4.45M	$ 4.40M	$ 3.88M
Diluted Average Shares	$ 12.56M	$ 42.47M	$ 33.54M	$ 4.45M	$ 4.40M	$ 3.88M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	$ 10.96K	-	-	$ 12.00K	$ 0.00	$ 45.00K
Total Expenses	$ 17.85M	$ 313.26K	$ 18.72M	$ 15.86M	$ 17.37M	$ 7.47M
Net Income From Continuing And Discontinued Operation	$ -17.15M	$ -19.53M	$ -15.09M	$ -12.86M	$ -14.78M	$ -1.64M
Normalized Income	$ -17.10M	-	-	$ -12.28M	$ -14.70M	$ -1.56M
Interest Expense	$ 79.96K	-	-	$ 69.50K	$ 128.52K	$ 134.31K
EBIT	$ -17.07M	$ -20.83M	$ -15.39M	$ -12.79M	$ -14.65M	$ -1.51M
EBITDA	$ -16.83M	$ -20.51M	$ -15.04M	$ -12.41M	$ -14.32M	$ -1.51M

Currency in USD

Addex Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing